Pasteur Institute, Merck abandon Covid-19 vaccine
- 25-Jan-2021
The partners announced a tie-up last May to develop a jab based on an existing measles vaccine, which was put into Phase 1 clinical trials in August
The partners announced a tie-up last May to develop a jab based on an existing measles vaccine, which was put into Phase 1 clinical trials in August